Prognostic value of 2-[(18)F]FDG PET-CT in metastatic melanoma patients receiving immunotherapy. Schweighofer-Zwink G, Manafi-Farid R, Kolblinger P, Hehenwarter L, et al. Eur J Radiol 2021;146:110107.

Read + Share

Amedeo Smart

Independent Medical Education

Schweighofer-Zwink G, Manafi-Farid R, Kolblinger P, Hehenwarter L, et al. Prognostic value of 2-[(18)F]FDG PET-CT in metastatic melanoma patients receiving immunotherapy. Eur J Radiol 2021;146:110107.
PMID: 34922117